Related Experiment Video
Updated: Oct 16, 2026

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Naltrexone does not block the subjective effects of oral Delta(9)-tetrahydrocannabinol in humans
1Department of Psychiatry, The University of Chicago, MC 3077, 5841 S. Maryland Ave, Chicago, IL 60637, USA. swachtel@yoda.bsd.uchicago.edu
Abstract:
Delta(9)-tetrahydrocannabinol (THC) and opioids have many common effects. In addition, some THC effects in laboratory animals can be blocked or attenuated by opioid antagonists. This suggests that opioid systems mediate or modulate some THC effects. To determine whether opioid systems mediate THC effects in humans, the effects of the opioid antagonist naltrexone on subjective responses to THC were examined in 14 marijuana users. Subjects participated in a double-blinded, cross-over design in which each subject received all combinations of naltrexone (0 or 50 mg) and THC (0, 7.5, or 15 mg). THC increased heart rate and self-reported drug effects, such as euphoria and marijuana-like effects, and decreased psychomotor performance. Naltrexone increased heart rate and decreased self-reported measures of vigor and hunger but did not alter any of the effects of THC. These results suggest that the subjective, physiological, and behavioral effects of THC in humans are not mediated through opioid systems.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
CNS Depressants: Alcohol and Nicotine
Opioid Receptors: Overview
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
Analgesia and Pain Management
Opioid Analgesics: Synthetic and Semisynthetic Opioids

